Velkavrh Manca, Paro-Panjan Darja, Benedik Evgen, Mis Natasa Fidler, Godnov Uros, Salamon Aneta Soltirovska
Department of Neonatology, University Children's Hospital, University Medical Centre Ljubljana, 1000Ljubljana, Slovenia.
Faculty of Medicine, University of Ljubljana, Slovenia.
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2019 Dec 1;40(3):91-98. doi: 10.2478/prilozi-2020-0008.
From the conception onward, certain parameters associated with maternal health may affect foetal body composition, growth and bone mineral content. The objective of the study was to determine the association between maternal vitamin D and adiponectin status with the anthropometrical measures of newborns, and bone health status measured by Quantitative Ultrasound (QUS) at birth.
Circulating 25OHD and adiponectin concentration were measured in 73 pregnant women. Correlations with the anthropometrical measures and bone health status in their infants were studied. Bone health was evaluated using QUS with the measurements of speed of sound (SOS, in m/s) and Z score on the right tibia.
There was no significant association between maternal 25OHD and newborn's anthropometrical measures at birth (weight p=0.35, length p=0.59 and head circumference p=0.47). There was a significant negative correlation between a maternal serum adiponectin and a) weight of infants at birth (R= -0.37, p=0.002); b) birth length (R= -0.31, p=0.008) and c) head circumference (R= -0.29, p=0.014). There was no significant correlation between maternal 25OHD blood levels during pregnancy and SOS in newborns (p=0.48). Additionally, a correlation between maternal adiponectin concentration during pregnancy and SOS in newborns was not significant (p=0.82).
Although a high prevalence of low 25OHD level among pregnant women was found, maternal vitamin D status did not influence growth and bone health of their offspring at birth. Maternal adiponectin levels in plasma showed an inverse relationship with anthropometrical measures of infants at birth, while no correlation with the newborn's bone health was found.
从受孕开始,某些与孕产妇健康相关的参数可能会影响胎儿的身体组成、生长和骨矿物质含量。本研究的目的是确定孕产妇维生素D和脂联素状态与新生儿人体测量指标以及出生时通过定量超声(QUS)测量的骨骼健康状况之间的关联。
测量了73名孕妇的循环25羟维生素D(25OHD)和脂联素浓度。研究了它们与婴儿人体测量指标和骨骼健康状况的相关性。使用QUS测量右侧胫骨的声速(SOS,单位为m/s)和Z评分来评估骨骼健康。
孕产妇25OHD水平与新生儿出生时的人体测量指标之间无显著关联(体重p = 0.35,身长p = 0.59,头围p = 0.47)。孕产妇血清脂联素与以下指标之间存在显著负相关:a)出生时婴儿体重(R = -0.37,p = 0.002);b)出生身长(R = -0.31,p = 0.008);c)头围(R = -0.29,p = 0.014)。孕期孕产妇25OHD血水平与新生儿SOS之间无显著相关性(p = 0.48)。此外,孕期孕产妇脂联素浓度与新生儿SOS之间的相关性也不显著(p = 0.82)。
尽管发现孕妇中25OHD水平低的患病率很高,但孕产妇维生素D状态并未影响其后代出生时的生长和骨骼健康。孕产妇血浆脂联素水平与出生时婴儿的人体测量指标呈负相关,而与新生儿骨骼健康无相关性。